Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020

Neeraj Sood; Paul Simon; Peggy Ebner; Daniel Eichner; Jeffrey Reynolds; Eran Bendavid; Jay Bhattacharya

doi:10.1001/jama.2020.8279

Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020

JAMA. 2020 Jun 16;323(23):2425-2427. doi: 10.1001/jama.2020.8279.

Authors

Neeraj Sood¹, Paul Simon², Peggy Ebner³, Daniel Eichner⁴, Jeffrey Reynolds⁵, Eran Bendavid⁶, Jay Bhattacharya⁶

Affiliations

¹ Schaeffer Center for Health Policy and Economics, Sol Price School of Public Policy, University of Southern California, Los Angeles.
² Los Angeles County Department of Public Health, Los Angeles, California.
³ Keck School of Medicine, University of Southern California, Los Angeles.
⁴ Sports Medicine Research and Testing Laboratory, Salt Lake City, Utah.
⁵ LRW Group, Los Angeles, California.
⁶ Stanford University School of Medicine, Palo Alto, California.

Abstract

This population epidemiology study investigates the prevalence of IgG and IgM antibodies to SARS-CoV-2 in Los Angeles County, California, as a marker of both active and past infections.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Antibodies, Viral / blood*
Betacoronavirus / immunology*
COVID-19
Coronavirus Infections / blood
Coronavirus Infections / epidemiology*
Coronavirus Infections / immunology
Female
Humans
Immunoglobulin G / blood
Immunoglobulin M / blood
Incidence
Los Angeles / epidemiology
Male
Middle Aged
Pandemics
Pneumonia, Viral / blood
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / immunology
SARS-CoV-2
Seroepidemiologic Studies
Young Adult

Substances

Antibodies, Viral
Immunoglobulin G
Immunoglobulin M